Blockade of proteasome activity disturbs the rhythm of synthesis of the protein marker of direct cell-cell interactions

[1]  V. Brodsky.  Circahoralian (Ultradian) metabolic rhythms , 2014, Biochemistry (Moscow).

[2]  N. Sharova,et al.  Immune proteasomes in the development of the rat immune system , 2013, Russian Journal of Bioorganic Chemistry.

[3]  A. Aguilar-Lemarroy,et al.  Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65 , 2013, Journal of Biomedical Science.

[4]  J. Yang,et al.  Circulating microRNA signatures in mice exposed to lipoteichoic acid , 2013, Journal of Biomedical Science.

[5]  Ernest Lawrence Rossi,et al.  Ultradian Rhythms in Life Processes , 2011, Springer London.

[6]  S. Hymowitz,et al.  Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination , 2011, Science.

[7]  V. Brodsky,et al.  Melatonin as the most effective organizer of the rhythm of protein synthesis in hepatocytes in vitro and in vivo , 2010, Cell biology international.

[8]  J. McCubrey,et al.  Novel combination of Celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells , 2010, Cell cycle.

[9]  W. Park,et al.  MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level. , 2010, Human & experimental toxicology.

[10]  M. Kukan,et al.  Effects of proteasome inhibitor, MG132, on proteasome activity and oxidative status of rat liver , 2008, Cell biochemistry and function.

[11]  T. Solov’eva,et al.  Isolation and characterization of a low-molecular-weight immunoglobulin-binding protein from Yersinia pseudotuberculosis , 2006, Biochemistry (Moscow).

[12]  N. Sharova,et al.  Peculiarities of proteasome pool formation in rat spleen and liver during postnatal development , 2006, Biochemistry (Moscow).

[13]  C. Richter-Landsberg,et al.  Proteasome inhibition by MG‐132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes , 2006, Glia.

[14]  S. V. Anisimov,et al.  Melatonin as antioxidant, geroprotector and anticarcinogen. , 2006, Biochimica et biophysica acta.

[15]  V. Brodsky,et al.  Direct cell–cell communication: a new approach derived from recent data on the nature and self‐organisation of ultradian (circahoralian) intracellular rhythms , 2005, Biological reviews of the Cambridge Philosophical Society.

[16]  H. Friess,et al.  The proteasome inhibitor MG132 induces apoptosis in human pancreatic cancer cells. , 2005, Oncology reports.

[17]  B. Kessler,et al.  Effects of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein metabolism in septic rats , 2004, International journal of experimental pathology.

[18]  S. Morley,et al.  The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complex. , 2004, European journal of biochemistry.

[19]  V. Brodsky,et al.  GANGLIOSIDE‐MEDIATED METABOLIC SYNCHRONIZATION OF PROTEIN SYNTHESIS ACTIVITY IN CULTURED HEPATOCYTES , 2000, Cell biology international.

[20]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[21]  A. Ciechanover.  Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. , 2013, Bioorganic & medicinal chemistry.

[22]  Herb Chen,et al.  MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype. , 2010, The Journal of surgical research.

[23]  N. Sharova,et al.  New approach to study of T cellular immunity development: parallel investigation of lymphoid organ formation and changes in immune proteasome amount in rat early ontogenesis. , 2009, Cellular immunology.

[24]  A. Ciechanover.  Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting* , 2005, Cell Death and Differentiation.

[25]  N. Lecture.  Intracellular Protein Degradation: From a Vague Idea, through the Lysosome and the Ubiquitin-Proteasome System, and onto Human Diseases and Drug Targeting , 2005 .

[26]  S. Morley,et al.  The proteasome inhibitor , MG 132 , promotes the reprogramming of translation in C 2 C 12 myoblasts and facilitates the association of hsp 25 with the eIF 4 F complex , 2004 .

[27]  D. Lloyd,et al.  Intracellular Time Keeping: Epigenetic Oscillations Reveal the Functions of an Ultradian Clock , 1992 .

[28]  N. Nechaeva,et al.  [Circahoral fluctuations in protein release from hepatocytes in a monolayer culture]. , 1982, Tsitologiia.

[29]  Brodskiĭ VIa,et al.  Circahoral fluctuations in protein release from hepatocytes in a monolayer culture , 1982 .